SHED

SHED provides a telehealth weight-loss program based on GLP-1 therapy (semaglutide and tirzepatide). It emphasizes comprehensive support: unlimited provider visits, health coaching, and a personalized program. The company claims most patients lose ~15% body weight and offers a 10% money-back guarantee after 16 weeks. Medication pricing starts at $199/month (compounded injectables) and includes other formats (drops, lozenges). SHED requires a minimum 2-month subscription. Patients complete an online intake; a licensed MD reviews it and prescribes weekly GLP-1 (often Wegovy) if approved. The service operates nationwide, with free shipping and supplemental peptide options.

Aggregate ratings, linked at source.

We don’t republish individual user quotes — too easy to misattribute, too easy to lose context. Below are the aggregate ratings from public review platforms with links to read actual reviews at the source. Counts are rounded down to a confident floor (e.g. 12,788 → 12,000+).

Click any source above to read the actual reviews. Ratings reflect the platform’s own reported aggregate at last verification (May 6, 2026).

What we like. Where we don’t.

Email corrections@epioneum.com with the field, the number we have, the number you believe is correct, and a primary or secondary source. We respond within 14 days.